Tema Oncology ETF (CANC)
- Expense ratio0.78%
- Net assets$202.6M
- Dividend yield0.05%
- 1-year return+30.41%
- Holdings58
CANC ETF price chart
CANC quote & trading statistics
CANC performance
Total return · as of October 18, 2026- YTD+14.68%
- 1 year+30.41%
- 3 years+20.58%/yr
- 1Y volatility
- 20.54%
- 3Y volatility
- 20.04%
- 3Y Sharpe ratio
- 0.92
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
CANC top 10 holdings
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | 5.44% |
| 2 | MRK | Merck & Company Inc | 5.23% |
| 3 | LLY | Eli Lilly and Company | 5.14% |
| 4 | UMRX | Cogent Biosciences Inc | 4.65% |
| 5 | NOVN | Novartis AG | 4.24% |
| 6 | GMAB | Genmab AS | 3.80% |
| 7 | BGNE | BeiGene Ltd | 3.73% |
| 8 | HALO | Halozyme Therapeutics Inc | 3.71% |
| 9 | EXEL | Exelixis Inc | 3.60% |
| 10 | ABBV | AbbVie Inc | 3.32% |
The top 10 holdings make up 42.9% of the fund (58 holdings in total). As of October 18, 2026.
About Tema Oncology ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
CANC ETF FAQ
What is the CANC expense ratio?
Tema Oncology ETF has a net expense ratio of 0.78%, or $78.00 a year for every $10,000 invested.
How much money is in CANC?
Tema Oncology ETF has about $202.6M in net assets.
What are the top holdings of CANC?
The largest positions in CANC are Revolution Medicines Inc (5.44%), Merck & Company Inc (5.23%), Eli Lilly and Company (5.14%). The fund holds 58 securities in total.
How has CANC performed?
CANC returned +30.41% over the past year, including reinvested distributions.
Does CANC pay dividends?
CANC has a dividend yield of 0.05%.
When was CANC launched?
Tema Oncology ETF began trading on August 14, 2023.